WSI, Chairman Park Jeongseop Acquires Company Shares... "Responsible Management and Enhancing Shareholder Value"

Park Jeong-seop, chairman of WSI, expressed a strong commitment to responsible management by purchasing company shares.

On the 4th, WSI announced that Chairman Park Jeong-seop acquired 68,515 shares of the company through on-market purchases. The purchase amount was approximately 123 million KRW.

As a result, Chairman Park's total number of shares held increased to 14,469,727 shares, representing a 48.19% stake.

This share purchase reflects Chairman Park's commitment to responsible management and enhancing shareholder value. The company explained that key executives, including Chairman Park, are considering additional purchases of company shares.

Chairman Park stated, "I decided to purchase company shares to practice responsible management under the judgment that the current stock price is undervalued. If the undervaluation continues, I am also considering additional share purchases based on confidence in the company's growth."

Meanwhile, WSI is actively diversifying its business to secure new growth engines. Last month, it completed the acquisition of IntroBioPharma, a company specializing in pharmaceutical research and development and manufacturing. Through this, the company plans to expand its business scope from pharmaceutical distribution to pharmaceutical research, development, and manufacturing. The subsidiary EasyMediBot is also advancing its surgical robot business. EasyMediBot successfully raised 2 billion KRW in Series A funding on the 1st.

This content was produced with the assistance of AI translation services.